, Tracking Stock Market Picks
Enter Symbol:
galena biopharma (GALE) [hlAlert]

down 33.48 %

galena biopharma (GALE) rated Buy with price target $11 by Maxim Group

Posted on: Tuesday,  Jan 21, 2014  9:25 AM ET by Maxim Group

Maxim Group rated Buy galena biopharma (NASDAQ: GALE) on 01/21/2014. Previously Maxim Group rated Buy galena biopharma (NASDAQ: GALE) on 11/05/2012.,
when the stock price was $2.24. Since then, galena biopharma has lost 33.48% as of 01/21/2016's recent price of $1.49.
If you would have followed the previous Maxim Group's recommendation on GALE, you would have lost 33.48% of your investment in 1172 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/21/2014 9:25 AM Buy
6.38 11.00
as of 10/17/2014
1 Week up  8.77 %
1 Month down  -16.21 %
3 Months down  -27.90 %
1 YTD down  -62.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2012 8:25 AM Buy
2.24 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy